Inhibrx Biosciences, Inc. (INBX) stock chart

INBXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30

$87.75−2.84 (-3.14%)

Close on Nov 12, 2026Market cap $1.29BP/E –Yield –

Daily, weekly, monthly, quarterly and yearly candles from end-of-day prices, adjusted for splits. Marks along the bottom: E for earnings, D for ex-dividend dates, S for stock splits. Drawings are saved in this browser for each symbol; indicators and chart settings carry across symbols.

See a number that looks wrong?